Shield CRC blood test demonstrates adherence of 95% in new study of 20,000 patients – Guardant Health
Guardant Health Inc announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based screening test demonstrates patient adherence of 95% in screening… read more.
